Cargando…
Thyroid-Stimulating Hormone Predicts Total Cholesterol and Low-Density Lipoprotein Cholesterol Reduction during the Acute Phase of COVID-19
A complex dysregulation of lipid metabolism occurs in COVID-19, leading to reduced total cholesterol (TC), LDL-cholesterol (LDL-C), and HDL-cholesterol (HDL-C) levels, along with a derangement of thyroid function, leading to reduced thyroid-stimulating hormone (TSH) levels. This study aimed to explo...
Autores principales: | Mannarino, Massimo Raffaele, Bianconi, Vanessa, Cosentini, Elena, Figorilli, Filippo, Colangelo, Cecilia, Giglioni, Francesco, Lombardini, Rita, Paltriccia, Rita, Pirro, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225372/ https://www.ncbi.nlm.nih.gov/pubmed/35743420 http://dx.doi.org/10.3390/jcm11123347 |
Ejemplares similares
-
The HACOR Score Predicts Worse in-Hospital Prognosis in Patients Hospitalized with COVID-19
por: Mannarino, Massimo Raffaele, et al.
Publicado: (2022) -
Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk
por: Figorilli, Filippo, et al.
Publicado: (2022) -
Lipoprotein(a) Does Not Predict Thrombotic Events and In-Hospital Outcomes in Patients with COVID-19
por: Bianconi, Vanessa, et al.
Publicado: (2023) -
Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren’s Syndrome
por: Bianconi, Vanessa, et al.
Publicado: (2023) -
Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19
por: Bianconi, Vanessa, et al.
Publicado: (2021)